Non-motor features of Parkinson disease
Anthony H V Schapira, K Ray Chaudhuri, Peter Jenner, Anthony H V Schapira, K Ray Chaudhuri, Peter Jenner
Abstract
Many of the motor symptoms of Parkinson disease (PD) can be preceded, sometimes for several years, by non-motor symptoms that include hyposmia, sleep disorders, depression and constipation. These non-motor features appear across the spectrum of patients with PD, including individuals with genetic causes of PD. The neuroanatomical and neuropharmacological bases of non-motor abnormalities in PD remain largely undefined. Here, we discuss recent advances that have helped to establish the presence, severity and effect on the quality of life of non-motor symptoms in PD, and the neuroanatomical and neuropharmacological mechanisms involved. We also discuss the potential for the non-motor features to define a prodrome that may enable the early diagnosis of PD.
References
- J Affect Disord. 2011 Jul;132(1-2):82-8
- Neurogastroenterol Motil. 2009 Feb;21(2):215-22
- Ann Neurol. 2013 Sep;74(3):337-47
- Br J Pharmacol. 2003 Aug;139(8):1425-32
- Arch Neurol. 2010 Jun;67(6):670-6
- Mov Disord. 2008 May 15;23(7):964-9
- J Parkinsons Dis. 2014;4(3):531-9
- Mov Disord. 2010 Aug 15;25(11):1646-51
- Mov Disord. 2011 Nov;26(13):2387-95
- Br J Pharmacol. 2006 Feb;147 Suppl 2:S25-40
- Mov Disord. 2009 Oct 30;24(14):2136-42
- Eur J Neurol. 2013 Mar;20(3):480-5
- Neurodegener Dis. 2013;11(2):79-92
- Mov Disord. 2002 Mar;17(2):366-71
- Brain. 2010 Jun;133(Pt 6):1755-62
- Prog Mol Biol Transl Sci. 2013;119:137-54
- Acta Neuropathol. 2007 Apr;113(4):421-9
- Ann Neurol. 1989 Apr;25(4):357-64
- Nat Rev Neurol. 2012 Apr 17;8(5):284-94
- Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S233-6
- Lancet. 2014 Aug 9;384(9942):545-55
- Neurosci Lett. 2006 Jun 19;401(1-2):146-9
- Neurogastroenterol Motil. 2014 Dec;26(12):1771-82
- Eur J Neurol. 2013 Dec;20(12):1517-23
- Eur J Neurol. 2015 Sep;22(9):1280-7
- J Clin Neurophysiol. 1997 Jan;14(1):2-31
- Mov Disord. 2014 Jun;29(7):897-903
- Sci Rep. 2012;2:898
- Lancet. 1995 Sep 30;346(8979):861-4
- Parkinsonism Relat Disord. 2014 May;20(5):535-40
- Brain. 2007 Jun;130(Pt 6):1586-95
- Brain Struct Funct. 2012 Apr;217(2):447-58
- Eur J Neurol. 2008 Jul;15(7):685-91
- Ann Intern Med. 2000 Sep 5;133(5):338-47
- Neurosci Res. 2008 Mar;60(3):314-8
- PLoS One. 2011 Apr 29;6(4):e19338
- Neurobiol Dis. 2012 Jan;45(1):305-9
- Sleep Med Rev. 2003 Apr;7(2):115-29
- Nat Rev Neurosci. 2015 Feb;16(2):109-20
- Mov Disord. 2014 Apr 15;29(5):634-50
- Eur J Neurosci. 2007 Oct;26(7):1902-11
- Eur J Neurol. 2013 Feb;20(2):231-5
- Parkinsonism Relat Disord. 2017 Feb;35:8-16
- Exp Neurol. 2009 Oct;219(2):574-82
- Mov Disord. 2000 Mar;15(2):212-5
- J Neurol Sci. 2010 Feb 15;289(1-2):81-8
- Eur J Neurosci. 2008 Jul;28(2):247-56
- Mov Disord. 2016 Jan;31(1):86-94
- Mov Disord. 2010 Apr 30;25(6):704-9
- Mov Disord. 2014 Jul;29(8):1010-8
- Brain. 2010 Nov;133(11):3434-43
- Lancet Neurol. 2015 Jun;14(6):625-39
- Prog Brain Res. 2010;184:53-87
- Neurobiol Dis. 2012 Aug;47(2):258-67
- Brain Res. 1994 Nov 7;663(1):140-4
- Neurology. 2008 Aug 12;71(7):481-5
- Clin Neuropharmacol. 1993 Oct;16(5):438-43
- Eur J Neurol. 2013 Jan;20(1):16-34
- Mov Disord. 2005 Dec;20(12):1557-63
- Mov Disord. 2010;25 Suppl 1:S98-103
- Arch Neurol. 2006 Sep;63(9):1343-4
- Lancet. 2004 Mar 20;363(9413):978-88
- Mov Disord. 2008 Apr 30;23(6):837-44
- Neurobiol Aging. 2013 Mar;34(3):928-35
- Mov Disord. 2008 Jan 30;23(2):183-9; quiz 313
- Nat Rev Neurol. 2015 Nov;11(11):625-36
- Lancet Neurol. 2015 Jan;14 (1):57-64
- Mov Disord. 2012 Apr;27(4):526-32
- Mov Disord. 2013 May;28(5):591-6
- Neurology. 1986 Jan;36(1):73-5
- J Neurol Sci. 2010 Feb 15;289(1-2):60-5
- Eur J Neurol. 2013 Aug;20(8):1113-20
- Neuropathol Appl Neurobiol. 2008 Jun;34(3):284-95
- Eur J Neurosci. 2004 Sep;20(5):1371-8
- J Neural Transm (Vienna). 2008;115(3):443-60
- J Pharmacol Exp Ther. 2003 Jul;306(1):401-6
- Brain Res. 1992 Jul 17;586(1):144-7
- Drugs. 2004;64(2):149-58
- J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):159-64
- Neurology. 2002 Feb 12;58(3):341-6
- Neurobiol Dis. 2012 Oct;48(1):9-19
- J Neurosci. 2005 Jun 22;25(25):6016-24
- PLoS One. 2015 May 11;10(5):e0126261
- PLoS One. 2012;7(4):e35371
- J Comp Neurol. 1989 Sep 15;287(3):373-92
- Clin Auton Res. 2006 Feb;16(1):46-54
- J Pharmacol Exp Ther. 2003 Sep;306(3):855-60
- J Urol. 2012 Apr;187(4):1491-7
- Brain. 2008 Jul;131(Pt 7):1903-11
- J Pharmacol Exp Ther. 1998 Jul;286(1):228-33
- Can J Neurol Sci. 2010 Jan;37(1):86-95
- Arch Neurol. 2008 Sep;65(9):1191-4
- Neurology. 2001 Aug 14;57(3):456-62
- Eur J Ophthalmol. 2011 Jan-Feb;21(1):24-9
- Mov Disord. 2011 Jan;26(1):188-90
- Mov Disord. 2016 Jan;31(1):45-52
- Brain. 1988 Feb;111 ( Pt 1):131-49
- Parkinsonism Relat Disord. 2011 Jul;17(6):431-6
- J Neural Transm (Vienna). 2011 May;118(5):821-39
- Neuropathol Appl Neurobiol. 2006 Jun;32(3):284-95
- Eur J Neurol. 2005 Nov;12(11):842-50
- Lancet. 2000 Apr 15;355(9212):1332-3
- Sleep. 2011 Aug 01;34(8):1119-25
- Brain. 2013 May;136(Pt 5):1568-77
- Eur J Neurosci. 2012 Mar;35(6):870-82
- Brain. 2014 May;137(Pt 5):1304-22
- Mov Disord. 2012 May;27(6):716-9
- Mov Disord. 2011 Oct;26 Suppl 3:S42-80
- Acta Neuropathol. 2012 Nov;124(5):665-80
- J Pain Symptom Manage. 2006 Nov;32(5):462-9
- Lancet Neurol. 2014 Jan;13(1):100-12
- PLoS One. 2007 Jun 06;2(6):e513
- Ann Neurol. 1996 Sep;40(3):399-410
- J Clin Invest. 2011 Feb;121(2):715-25
- Brain. 2005 Jun;128(Pt 6):1314-22
- J Parkinsons Dis. 2011;1(4):321-7
- J Nucl Med. 2000 Jan;41(1):71-7
- Mov Disord. 2012 Mar;27(3):379-86
- PLoS One. 2013;8(4):e60691
- BMC Ophthalmol. 2012 Oct 02;12:54
- Brain. 2010 Jun;133(Pt 6):1747-54
- Ann Neurol. 2014 Mar;75(3):351-62
- J Neurochem. 1985 Jan;44(1):117-27
- Neuropathol Appl Neurobiol. 2008 Aug;34(4):466-7
- Drugs Aging. 2008;25(8):665-82
- Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
- Brain. 2013 Mar;136(Pt 3):739-50
- Lancet Neurol. 2015 May;14(5):518-31
- J Neurol Sci. 2001 Jun 15;187(1-2):55-9
- Mov Disord. 2006 Aug;21(8):1123-30
- J Affect Disord. 2012 Jul;139(2):103-12
- Acta Neuropathol. 2011 Jul;122(1):61-74
- Neurobiol Dis. 2014 Mar;63:20-4
- J Neurol Neurosurg Psychiatry. 2009 May;80(5):489-92
- Mov Disord. 2014 Apr 15;29(5):663-72
- Mov Disord. 2006 Jul;21(7):916-23
- J Neurol Neurosurg Psychiatry. 1991 May;54(5):388-96
- J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74
- J Neurol. 2014 Dec;261(12):2319-28
- Neurobiol Dis. 2012 Dec;48(3):474-80
- Neurobiol Dis. 2012 Jun;46(3):527-52
- J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S25-31
- Mov Disord. 2016 Aug;31(8):1095-102
- J Neurosci. 2009 Jun 24;29(25):8103-13
- Ann Neurol. 2002 Feb;51(2):156-64
- Lancet Neurol. 2013 May;12(5):514-24
- Mov Disord. 2006 Sep;21(9):1343-9
- Trends Neurosci. 1990 Jul;13(7):296-302
- Neurobiol Dis. 2012 Jun;46(3):565-71
- Neurology. 2010 Mar 16;74(11):924-31
- Pain. 2009 Jan;141(1-2):173-7
- Mov Disord. 2011 Mar;26(4):621-8
- Lancet Neurol. 2010 Nov;9(11):1070-7
- Mov Disord. 2015 Oct;30(12):1623-31
- Handb Clin Neurol. 2013;117:111-7
- Neurosci Lett. 2009 Apr 3;453(2):77-80
- Nucl Med Biol. 2006 Jan;33(1):37-42
- Neurogastroenterol Motil. 2012 Apr;24(4):e202-5
- Parkinsons Dis. 2011;2011:908306
- Mol Genet Metab. 2013 Jun;109(2):221-3
- Parkinsonism Relat Disord. 2014 Feb;20(2):217-21
- Parkinsonism Relat Disord. 2006 May;12(4):253-6
- Neurobiol Dis. 2013 Aug;56:145-55
- Mov Disord. 1999 Jan;14(1):117-21
- Nucl Med Biol. 2009 Aug;36(6):623-9
- Curr Opin Neurol. 2013 Aug;26(4):395-400
- Parkinsonism Relat Disord. 2013 Mar;19(3):285-94; discussion 285
- Mov Disord. 2015 Sep 15;30(11):1490-504
- Eur J Neurol. 2013 Oct;20(10):1375-82
- Mov Disord. 2012 May;27(6):708
- Neurology. 2004 Oct 26;63(8):1409-16
- Brain Res. 1991 Aug 2;555(2):181-92
- J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1140-2
- J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):803-9
- NeuroRehabilitation. 2005;20(4):335-41
- Neurology. 2009 Mar 10;72(10):886-92
- Neurosci Lett. 1988 Apr 22;87(1-2):46-50
- Eur J Neurol. 2014 Mar;21(3):541-4
- J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):23-30
- Am J Psychiatry. 1978 Jun;135(6):669-75
- Acta Neuropathol. 2014 Apr;127(4):477-94
- AJNR Am J Neuroradiol. 2011 Apr;32(4):677-81
- Brain. 2014 May;137(Pt 5):1481-95
- Eur J Neurosci. 2012 Jun;35(12):1894-907
- Neurourol Urodyn. 2014 Jan;33(1):59-66
- J Neural Transm. 1975;37(2):175-82
- Mov Disord. 2015 Apr;30(4):517-24
- Neurogastroenterol Motil. 2012 Sep;24(9):e425-36
- Neurotox Res. 2010 Feb;17(2):114-29
- Lancet Neurol. 2015 Dec;14(12):1161-70
- Neuropharmacology. 1993 Apr;32(4):315-21
- Neurobiol Dis. 2009 Oct;36(1):96-102
- Mov Disord. 2014 Dec;29(14):1796-801
- Philos Trans R Soc Lond B Biol Sci. 2007 May 29;362(1481):917-32
- J Neurol. 2005 Jul;252(7):753-64
- Mov Disord. 2014 Nov;29(13):1591-8
- Neurobiol Dis. 2008 Nov;32(2):319-27
- Brain. 1999 Sep;122 ( Pt 9):1637-50
- Nat Rev Neurol. 2010 Jun;6(6):309-17
- Brain. 2007 Nov;130(Pt 11):2770-88
- Eur J Neurol. 2014 May;21(5):766-72
- Neurourol Urodyn. 2011 Jan;30(1):188-93
- Brain. 2007 Jun;130(Pt 6):1577-85
- J Neural Transm (Vienna). 2013 Apr;120(4):571-6
- Ann Neurol. 2004 Aug;56(2):173-81
- Science. 2012 Nov 16;338(6109):949-53
- Lancet Neurol. 2006 Mar;5(3):235-45
- Eur J Nucl Med Mol Imaging. 2012 Dec;39(12 ):1937-48
- Neurobiol Aging. 2004 Jan;25(1):131-8
- Parkinsonism Relat Disord. 2009 May;15(4):287-94
- Neurobiol Dis. 2012 Jun;46(3):508-26
- J Neurosci. 2003 Jul 16;23(15):6351-6
- Mov Disord. 2007 Jun 15;22(8):1175-8
- Mov Disord. 2008 Jul 30;23(10):1361-9
- Mov Disord. 1997 Nov;12(6):877-84
- Neurosci Biobehav Rev. 2005;29(7):1047-56
- Am J Physiol Heart Circ Physiol. 2015 Feb 1;308(3):H250-7
- Neurology. 1997 Dec;49(6):1570-6
- Mov Disord. 2004 Aug;19(8):885-91
- J Clin Pharmacol. 2016 Jul;56(7):852-61
- Front Behav Neurosci. 2013 Nov 26;7:175
- Mov Disord. 2000 Jul;15(4):669-77
- Psychiatry Res. 2008 Jul 15;163(2):171-82
- Eur J Neurol. 2009 Sep;16(9):982-9
- Lancet Neurol. 2009 May;8(5):464-74
- Neuropsychologia. 2002;40(13):2257-67
- Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
- PLoS One. 2013 Oct 30;8(10 ):e77509
- Neurourol Urodyn. 2001;20(1):105-13
- Mov Disord. 2005 Feb;20(2):130-40
- Curr Treat Options Neurol. 2004 May;6(3):191-200
- Parkinsonism Relat Disord. 2009 Feb;15(2):81-7
- Arch Neurol. 2000 Apr;57(4):470-5
- Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3214-5
- Neurology. 2015 Mar 17;84(11):1104-13
- Eur J Neurol. 2013 Feb;20(2):259-65
- Ann Neurol. 2014 Mar;75(3):331-3
- J Neurosci. 2008 Mar 5;28(10):2471-84
- Mov Disord. 2009 Jul 30;24(10):1468-74
- Neurobiol Dis. 2012 Jun;46(3):581-9
- Neurology. 2013 Feb 26;80(9):800-9
- Brain. 2002 Nov;125(Pt 11):2431-45
- Auton Neurosci. 2012 Aug 16;169(2):77-86
- J Neurol. 2010 Feb;257(2):217-23
- Neurology. 2010 Sep 7;75(10):857-63
- Parkinsonism Relat Disord. 2009 Feb;15(2):144-8
- J Neural Transm (Vienna). 2009 Nov;116(11):1493-501
- Neuroscience. 2008 Oct 28;156(4):830-40
- JAMA Neurol. 2015 Feb;72(2):201-8
- Mov Disord. 2006 Nov;21(11):1879-91
- Mov Disord. 2009 Apr 30;24(6):906-14
- Eur J Neurol. 2013 Oct;20(10):1398-404
- Front Neurol. 2013 Jul 23;4:103
Source: PubMed